Similar articles for PMID: 12629065

Year	Number of Results
1990	1
1991	1
1993	1
1994	1
1997	2
1999	3
2000	3
2002	6
2003	6
2004	2
2005	5
2006	8
2007	8
2008	4
2009	5
2010	2
2011	5
2012	3
2013	2
2014	6
2015	2
2017	1
2018	1
2020	1
2021	1
2024	0

1

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.

Aktas O, Waiczies S, Smorodchenko A, Dorr J, Seeger B, Prozorovski T, Sallach S, Endres M, Brocke S, Nitsch R, Zipp F. Aktas O, et al. J Exp Med. 2003 Mar 17;197(6):725-33. doi: 10.1084/jem.20021425. Epub 2003 Mar 10. J Exp Med. 2003. PMID: 12629065 Free PMC article.

2

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.

Youssef S, Stüve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, Zamvil SS. Youssef S, et al. Nature. 2002 Nov 7;420(6911):78-84. doi: 10.1038/nature01158. Nature. 2002. PMID: 12422218

3

[Effects of atorvastatin in multiple sclerosis].

Koh CS. Koh CS. Nihon Rinsho. 2003 Aug;61(8):1455-60. Nihon Rinsho. 2003. PMID: 12962038 Review. Japanese.

4

Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.

Dunn SE, Youssef S, Goldstein MJ, Prod'homme T, Weber MS, Zamvil SS, Steinman L. Dunn SE, et al. J Exp Med. 2006 Feb 20;203(2):401-12. doi: 10.1084/jem.20051129. Epub 2006 Feb 13. J Exp Med. 2006. PMID: 16476765 Free PMC article.

5

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE.

Mix E, Ibrahim SM, Pahnke J, Glass A, Mazón-Peláez I, Lemcke S, Koczan D, Gimsa U, Bansemer S, Scheel T, Karopka T, Böttcher T, Müller J, Dazert E, Antipova V, Hoffrogge R, Wree A, Zschiesche M, Strauss U, Kundt G, Warzok R, Gierl L, Rolfs A. Mix E, et al. J Autoimmun. 2006 Dec;27(4):251-65. doi: 10.1016/j.jaut.2006.09.006. Epub 2006 Nov 3. J Autoimmun. 2006. PMID: 17085013

6

Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.

Weber MS, Prod'homme T, Youssef S, Dunn SE, Steinman L, Zamvil SS. Weber MS, et al. J Neuroinflammation. 2014 Feb 6;11:29. doi: 10.1186/1742-2094-11-29. J Neuroinflammation. 2014. PMID: 24498870 Free PMC article.

7

Tackling multiple sclerosis.

Wekerle H. Wekerle H. Nature. 2002 Nov 7;420(6911):39-40. doi: 10.1038/420039a. Nature. 2002. PMID: 12422206 No abstract available.

8

Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.

Nath N, Giri S, Prasad R, Singh AK, Singh I. Nath N, et al. J Immunol. 2004 Jan 15;172(2):1273-86. doi: 10.4049/jimmunol.172.2.1273. J Immunol. 2004. PMID: 14707106

9

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.

Stüve O, Youssef S, Weber MS, Nessler S, von Büdingen HC, Hemmer B, Prod'homme T, Sobel RA, Steinman L, Zamvil SS. Stüve O, et al. J Clin Invest. 2006 Apr;116(4):1037-44. doi: 10.1172/JCI25805. Epub 2006 Mar 16. J Clin Invest. 2006. PMID: 16543951 Free PMC article.

10

Atorvastatin interferes with activation of human CD4(+) T cells via inhibition of small guanosine triphosphatase (GTPase) activity and caspase-independent apoptosis.

Brinkkoetter PT, Gottmann U, Schulte J, van der Woude FJ, Braun C, Yard BA. Brinkkoetter PT, et al. Clin Exp Immunol. 2006 Dec;146(3):524-32. doi: 10.1111/j.1365-2249.2006.03217.x. Clin Exp Immunol. 2006. PMID: 17100774 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

75 results

Results by year